The modulatory role of dendritic cell-T cell cross-talk in breast cancer: Challenges and prospects

M Shahverdi, J Masoumi, F Ghorbaninezhad… - Advances in Medical …, 2022 - Elsevier
Antigen recognition and presentation are highlighted as the first steps in developing
specialized antigen responses. Dendritic cells (DCs) are outstanding professional antigen …

[HTML][HTML] Immunotherapy and immunobiomarker in breast cancer: Current practice and future perspectives

K Liu, X Mao, T Li, Z Xu, R An - American Journal of Cancer …, 2022 - ncbi.nlm.nih.gov
Among the new cancer cases and resulting deaths among women worldwide, breast cancer
is the most significant threat to women's health. In recent years, immunotherapy was initially …

PKHB1, a thrombospondin-1 peptide mimic, induces anti-tumor effect through immunogenic cell death induction in breast cancer cells

KM Calvillo-Rodríguez, R Mendoza-Reveles… - …, 2022 - Taylor & Francis
Breast cancer is the most commonly diagnosed cancer and the leading cause of cancer
death in women worldwide. Recent advances in the field of immuno-oncology demonstrate …

Newly synthesized heteronuclear ruthenium (II)/ferrocene complexes suppress the growth of mammary carcinoma in 4T1-treated BALB/c mice by promoting activation …

MM Milutinović, PP Čanović, D Stevanović… - …, 2018 - ACS Publications
The two new heterometallic Ru (II)-tpy/ferrocene complexes [Ru (tpy) Cl2 (mtefc)](1) and [Ru
(tpy) Cl2 (mtpfc)](2)(where tpy= 2, 2′: 6′, 2′′-terpyridine, mtefc=(2-(methylthio) ethyl) …

The role of the tumor microenvironment in developing successful therapeutic and secondary prophylactic breast cancer vaccines

B Gordon, VK Gadi - Vaccines, 2020 - mdpi.com
Breast cancer affects roughly one in eight women over their lifetime and is a leading cause
of cancer-related death in women. While outcomes have improved in recent years …

IL-12 conditioning of peripheral blood mononuclear cells from breast cancer patients promotes the zoledronate-induced expansion of γδ T cells in vitro and enhances …

L Assy, SM Khalil, M Attia, ML Salem - International Immunopharmacology, 2023 - Elsevier
Background In a series of our preclinical studies, we have reported that conditioning of α/β
CD8+ T cells in vitro with interleukin-12 (IL-12) during their expansion improves their homing …

A nanobody against cytotoxic t-lymphocyte associated antigen-4 increases the anti-tumor effects of specific cd8+ T cells

Z Tang, F Mo, A Liu, S Duan, X Yang… - Journal of …, 2019 - ingentaconnect.com
Adoptive cell-based immunotherapy typically utilizes cytotoxic T lymphocytes (CTLs),
expanding these cells ex vivo. Such expansion is traditionally accomplished through the use …

Potential role of immunotherapy for advanced breast cancer

RA de Mello, GA Amaral, CC Tajima, H Tadokoro… - …, 2021 - Taylor & Francis
Breast cancer (BC) is the most common malignancy among women–in 2018 alone, 2.1
million new cases were diagnosed worldwide. Advanced BC includes both locally …

Biological and molecular studies on specific immune cells treated with checkpoint inhibitors for the thera-personal approach of breast cancer patients (ex-vivo study)

ME El-Houseini, MS Arafat, AM El-Husseiny… - Oncology …, 2022 - pmc.ncbi.nlm.nih.gov
Immunotherapy becomes a promising line of treatment for breast cancer (BC) however, its
success rate is still limited. Methods The study was designed to optimize the condition for …

Imunoterapia ativa para o cancro da mama: potenciais estratégias terapêuticas

DFLF de Oliveira - 2018 - search.proquest.com
O estágio curricular é a etapa final do nosso percurso académico enquanto estudantes de
Ciências Farmacêuticas, constituindo um elo de ligação entre a realidade académica e …